INOVIQ is a biotechnology company developing exosome-based diagnostics and therapeutics, with a focus on cancer. Its work includes technologies for isolating and analysing exosomes—small particles released by cells—and biomarker programs intended to support disease detection or monitoring. The company also operates diagnostic offerings while …
Micro-X develops compact X-ray products using a proprietary carbon-nanotube emitter technology. Its programs have included mobile medical imaging through Rover, computed-tomography development for stroke assessment and security-imaging applications. The technology is intended to reduce the size and weight of conventional X-ray systems, opening use …
Atomo Diagnostics designs rapid-diagnostic test devices intended to simplify sample collection, testing and result interpretation. Its product range includes integrated platforms used with lateral-flow assays and the Atomo HIV Self Test. The company works with diagnostic partners as well as on branded products, combining …
Careteq is an Australian clinical health-technology company focused on tools that support care delivery, medication management and independent living. Its portfolio includes HMR Referrals, a software service connecting general practitioners with accredited pharmacists for Home Medicines Reviews, and Sofihub, an adaptive-care technology platform designed …
Nexalis Therapeutics, formerly Inhalerx, is an Australian clinical-stage drug developer working on rapid-onset inhaled therapies for pain management and mental health. Its stated pipeline includes IRX-211 for breakthrough cancer pain, IRX-616a for panic disorder and SRX-25 for treatment-resistant depression. The company’s development strategy includes …
BCAL Diagnostics is developing BREASTEST, a blood-based test intended to support breast cancer detection. The company’s work centres on lipid biomarkers and a laboratory testing workflow, with development spanning clinical validation, regulatory preparation and commercial implementation. BCAL’s stated objective is to add a blood …
Biome Australia reported record FY2026 salesRevenueof A$23.9 million, describing Biome Daily as the leading probiotic product by units sold in Australian community pharmacies. The June half delivered revenue of about A$11.5 million, up 20% on the prior year, and June marked the first month …
Paradigm confirmed it completed enrolment in its pivotal Phase 3 knee osteoarthritis study, PARA_OA_012, ahead of schedule. According to company disclosures, the randomised, double-blind, placebo-controlled trial recruited 538 participants across roughly 65 clinical sites in Australia, the United States, Hong Kong and Moldova, exceeding …
Ansell manufactures and distributes protective gloves and personal protective equipment across two divisions, Industrial and Healthcare, employing more than 15,000 people in over 55 countries and serving customers in more than 100 nations from its base in Richmond, Victoria. Directors, recently made on-market share …
Vitrafy has continued to advance its cryopreservation platform, which it delivers through a managed-service model built around its Smart Freezing and Smart Thawing devices, integrated with its LifeChain software and Smart Packaging systems. The company has highlighted the regulatory standing of its devices and …